Center for Pharmaceutical Biotechnology and Nanomedicine, Pharmaceutical Department, Northeastern University, Boston, Massachusetts 02115, USA.
Mol Pharm. 2012 Apr 2;9(4):930-6. doi: 10.1021/mp200519y. Epub 2012 Mar 15.
Nanotechnology is playing an increasing role in targeted drug delivery into pathological tissues. Drug-loaded pharmaceutical nanocarriers can be delivered into diseased sites by passive targeting (spontaneous accumulation of nanocarriers in the areas with affected vasculature) or by active targeting (via site-specific ligands attached to the surface of drug-loaded nanocarriers). Subsequent level of targeting requires cellular internalization of nanocarriers and their specific association with certain individual cell organelles. The control over intracellular distribution of pharmaceutical nanocarriers requires effective and noninvasive methods of their visualization inside cells. In an attempt to enhance cellular internalization of pharmaceutical nanocarriers and their association with mitochondria specifically, we have prepared three types of cationic liposomes and investigated their intracellular distribution. The analysis was performed using Raman microspectroscopy in order to provide morphological information as well as biochemical signatures of the sample. It was demonstrated that Raman microscopy allows evaluation of the extent of mitochondrial association depending on the liposome composition.
纳米技术在靶向药物递送到病变组织中发挥着越来越重要的作用。载药的药物纳米载体可以通过被动靶向(纳米载体在受影响的血管区域自发积累)或主动靶向(通过连接到载药纳米载体表面的特异性配体)递送到病变部位。随后的靶向水平需要纳米载体的细胞内化及其与某些特定细胞细胞器的特异性结合。对药物纳米载体细胞内分布的控制需要对其在细胞内可视化的有效和非侵入性方法。为了增强药物纳米载体的细胞内化及其与线粒体的特异性结合,我们制备了三种类型的阳离子脂质体,并研究了它们的细胞内分布。使用拉曼显微镜对其进行了分析,以提供样品的形态信息和生化特征。结果表明,拉曼显微镜可以根据脂质体的组成评估与线粒体结合的程度。